T 0108/09 (Fulvestrant for treating resistant breast cancer/ASTRA ZENECA AB) of 14.02.2013
- European Case Law Identifier
- ECLI:EP:BA:2013:T010809.20130214
- Date of decision
- 14 February 2013
- Case number
- T 0108/09
- Petition for review of
- -
- Application number
- 01917289.9
- IPC class
- A61K 31/565A61P 35/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Use of fulvestrant in the treatment of resistant breast cancer
- Applicant name
- AstraZeneca AB
- Opponent name
- Teva Pharmaceutical Industries Ltd.
- Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 83
- Keywords
- Added matter (no)
Sufficiency of disclosure, novelty and inventive step (yes) - Catchword
- -
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is maintained as granted.